NCT03867682 2023-08-04Venetoclax and Lintuzumab-Ac225 in AML PatientsActinium PharmaceuticalsPhase 1/2 Unknown38 enrolled
NCT04190433 2023-05-24Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialMayo ClinicPhase 2 Withdrawn